Log in
Registration
Українська
English
Search for:
Home
Online Publication
Current Issue
Issue Archive
Authors
About
Information About the Journal
Focus and Scope
Indexing
For Authors
Submission Guidelines and Requirements
Peer Review
Article Processing Charges
Copyright and Licensing
Policies
Editorial Policy
Plagiarism Policy
Archiving Policy
Policy on the Use of Artificial Intelligence (AI) and AI-Supported Technologies
Open Access
Procedure for the Retraction of Published Articles
Ethical Issues
Publication Ethics
Procedure for Handling Complaints Regarding Ethical Breaches
Privacy Statement
International Standards and Principles of Operation
Organization of anticancer fight
Tumors of the chest cavity
Tumors of abdominal organs
Tumors of skin, soft tissues, bones
Breast tumor
Oncogynecology
Tumors of the head and neck
Oncurology
Oncohematology
Radiation diagnostics, radiation therapy
Experimental studies
Magazine online
All news
Rubric : Chemotherapy of solid tumors
A clinical case of treating of a patient with melanoma using checkpoint inhibitor pembolizumab (anti-PD-1 monoclonal antibody)
Author:Kosinova V.G. №4(28) 2017
Antitumor therapy for patients with diabetes mellitus
Authors: Shepil A.V. Vysotsky A.G. Sivak L.A. №4(28) 2017
In situ immune response after perioperative chemotherapy in patients with locally advanced breast cancer
Authors: Verovkina N.O. Sivak L.A. Lyalkin S. Krotevych M.S. №3(27) 2017
The applying of chemotherapy in oncologic patients with functional renal lesions
Authors: Sivak L.A. Kryachok I. Ivanov D.D. Tarasenko T. №3(27) 2017
Breast cancer immunotherapy: importance, prospects, problems
Authors: Sivak L.A. Verovkina N.O. №2(26) 2017
Method of improving the quality of life in patients receiving anthracycline-containing chemotherapy
Authors: Askоlskiy А.В. Sivak L.A. Shevchuk L. Mаydаnеvich N.... №2(26) 2017
Influence of clinical factors of unfavorable prognosis on the results of treatment of children with malignant solid neoplasms of high-risk groups (department’s experience)
Authors: Klymniuk G.I. Izhovsky O.Y. Pavlik S.V. Shayda E.V.... №2(26) 2017
The influence of allelic polymorphism of the gene CCR5 on the course of locally advanced breast cancer
Authors: Sivak L.A. Verevkina N. Gorovenko N.G. Lyalkin S.... №1(25) 2017
Prevention of early anthracycline-induced cardiotoxicity in patients with breast cancer
Authors: Askоlskiy А.В. Sivak L.A. Zharinov O.I. Antomonov M.Y.... №1(25) 2017
The impact of intratumoral hENT1 expression on survival in patients with pancreatic cancer treated with gemcitabine and tegafur in adjuvant setting
Authors: Dronov O.I. Zemskov S.V. Grabovyi A.N. №4(24) 2016
Modern approaches to the treatment of inoperable non-small cell lung cancer
Authors: Klimаnоv М.Yu. Sivak L.A. Tarasenko T. Askоlskiy А.В.... №4(24) 2016
Innovative breakthrough in cancer immunotherapy: pembrolizumab opportunities
Author:Maltsev D.V. №4(24) 2016
Manifestations of early anthracycline cardiotoxicity in patients with breast cancer receiving combination chemotherapy
Authors: Askоlskiy А.В. Sivak L.A. Zharinov O.I. Antomonov M.Y.... №4(24) 2016
The clinical case of multiple primary cancer
Authors: Sivak L.A. Tarasenko T. Klimаnоv М.Yu. Lyalkin S.... №3(23) 2016
Prognostic and predictive value of the biological markers in locally advanced breast cancer
Authors: Sivak L.A. Verevkina N. Lyalkin S. Mаydаnеvich N.... №4(20) 2015
1
2
3
»